Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, Sanofi 13.284.
Pfizer vs Sanofi: Revenue Comparison
Pfizer (PFE) and Sanofi (SNY) are peers in Vaccines. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $13.3B for Sanofi. Pfizer leads on revenue.
Pfizer's gross margin is 72.8% versus 75.5% for Sanofi. Pfizer's net margin is -1.6% versus 2.8% for Sanofi.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Sanofi.| Metric | Pfizer | Sanofi |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $13.28B |
| Cost of Revenue | $4.09B | $3.26B |
| Gross Profit | $10.94B | $10.03B |
| Operating Income | $4.71B | $2.58B |
| Net Income | $-246.00M | $370.00M |
| R&D Expense | $2.81B | $2.41B |
| Earnings Per Share | -$0.04 | $0.15 |
| Gross Margin | 72.8% | 75.5% |
| Operating Margin | 31.3% | 19.4% |
| Net Profit Margin | -1.6% | 2.8% |
| Free Cash Flow | $302.00M | $4.22B |
| Cumulative Free Cash Flow | $356.70B | $51.81B |
| Operating Cash Flow | $835.00M | $5.85B |
| Cash & Equivalents | $976.00M | $6.86B |